Published in Arch Pharm Ber Dtsch Pharm Ges on January 01, 1969
Alkaline transfer of DNA to plastic membrane. Biochem Biophys Res Commun (1984) 6.32
Mutational analysis of the Golgi retention signal of bovine beta-1,4-galactosyltransferase. J Biol Chem (1993) 1.44
Similarity of the nucleotide sequences of rat alpha-lactalbumin and chicken lysozyme genes. Nature (1984) 1.43
Molecular cloning and sequence of a cDNA coding for bovine lipoprotein lipase. Proc Natl Acad Sci U S A (1987) 1.39
Cloning and sequencing of cDNA of bovine N-acetylglucosamine (beta 1-4)galactosyltransferase. Proc Natl Acad Sci U S A (1986) 1.25
Complete sequence analysis of cDNA clones encoding rat whey phosphoprotein: homology to a protease inhibitor. Proc Natl Acad Sci U S A (1982) 1.15
Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal Biochem (1990) 1.13
Crystal structure of lactose synthase reveals a large conformational change in its catalytic component, the beta1,4-galactosyltransferase-I. J Mol Biol (2001) 1.11
Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J Cancer Res Clin Oncol (1992) 1.11
alpha-Lactalbumin (LA) stimulates milk beta-1,4-galactosyltransferase I (beta 4Gal-T1) to transfer glucose from UDP-glucose to N-acetylglucosamine. Crystal structure of beta 4Gal-T1 x LA complex with UDP-Glc. J Biol Chem (2001) 1.07
Synthesis of simian virus 40 DNA in isolated nuclei. Proc Natl Acad Sci U S A (1974) 1.07
DNA and gene therapy: transfer of mouse DNA to human and mouse embryonic cells by polyoma pseudovirions. Proc Natl Acad Sci U S A (1971) 1.02
Formation of nucleoprotein complexes between polyoma empty capsides and DNA. J Virol (1975) 1.01
Architecture of the sugar binding sites in carbohydrate binding proteins--a computer modeling study. Int J Biol Macromol (1998) 1.01
Rat alpha-lactalbumin has a 17-residue-long COOH-terminal hydrophobic extension as judged by sequence analysis of the cDNA clones. Proc Natl Acad Sci U S A (1981) 0.99
Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells. Cancer Res (1983) 0.97
alpha-Lactalbumin content of rat mammary carcinomas and the effect of pituitary stimulation. Cancer Res (1977) 0.95
Purification and properties of two forms of rat alpha-lactalbumin. J Biol Chem (1978) 0.94
Partial purification of rat alpha-lactalbumin mRNA. Nucleic Acids Res (1977) 0.89
Cell-cycle-specific and serum-dependent expression of gamma-actin mRNA in Swiss mouse 3T3 cells. Mol Cell Biol (1988) 0.88
Active site studies of bovine alpha1-->3-galactosyltransferase and its secondary structure prediction. Biochim Biophys Acta (2000) 0.87
Expression of deletion constructs of bovine beta-1,4-galactosyltransferase in Escherichia coli: importance of Cys134 for its activity. Protein Eng (1993) 0.86
Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes. J Med Chem (1980) 0.86
Molecular dynamics simulations of high-mannose oligosaccharides. Glycobiology (1994) 0.85
Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma. J Med Chem (1988) 0.85
[Antimicrobial and tumor-inhibiting properties of dithiourethane and studies on the mechanism of action. 16. Cytostatica]. Pharmazie (1972) 0.85
Expression of bovine beta-1,4-galactosyltransferase cDNA in COS-7 cells. Proc Natl Acad Sci U S A (1989) 0.85
Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma. J Cancer Res Clin Oncol (1995) 0.84
Molecular dynamics simulations of asialoglycoprotein receptor ligands. Biochemistry (1993) 0.83
Platinum compounds with estrogen receptor affinity. Cancer Treat Rev (1990) 0.81
alpha-Lactalbumin mRNA in 4-day lactating rat mammary gland. Proc Natl Acad Sci U S A (1978) 0.81
1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties. J Med Chem (1982) 0.80
Synthesis of simian virus 40 DNA in isolated nuclei. Biochem Biophys Res Commun (1974) 0.80
The polyoma pseudovirion--its properties, production, and use in transferring DNA to mouse and human cells. Johns Hopkins Med J Suppl (1973) 0.79
Controversial iduronate ring conformation in dermatan sulphate. Glycobiology (1995) 0.79
Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part II--The antileukemic effect. Arch Pharm (Weinheim) (1989) 0.79
Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1. J Biomol Struct Dyn (1998) 0.78
[Synthesis of 14C-anpirtoline]. Arch Pharm (Weinheim) (1988) 0.78
Dichloro-[1-(hydroxyphenyl)-2-phenylethylenediamine]platinum(II) complexes: testing on the human ovarian cancer cell lines NIH: OVCAR3 and SK OV 3. Arch Pharm (Weinheim) (1992) 0.78
Different response of murine and human mammary tumour models to a series of diastereoisomeric [1,2-bis(difluorophenyl) ethylenediamine]dichloroplatinum(II) complexes. J Cancer Res Clin Oncol (1991) 0.78
A rapid luciferase transfection assay for transcription activation effects and stability control of estrogenic drugs in cell cultures. J Cancer Res Clin Oncol (1994) 0.78
Three dimensional structure of the soybean agglutinin Gal/GalNAc complexes by homology modeling. J Biomol Struct Dyn (1998) 0.78
[The mode of local anesthetic action of cinchocaine homologues]. Arzneimittelforschung (1970) 0.78
Milk protein gene expression in the rat mammary gland. Crit Rev Food Sci Nutr (1982) 0.77
Benzylamines: synthesis and evaluation of antimycobacterial properties. J Med Chem (1984) 0.77
Correction to erythromycin ototoxicity. Drug Intell Clin Pharm (1981) 0.77
Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines. Cancer Res (1991) 0.77
Molecular dynamics simulation of alpha-lactalbumin and calcium binding c-type lysozyme. Protein Eng (1999) 0.77
Investigations on the antiproliferative effects of amino acid antagonists targeting for aminoacyl-tRNA synthetases. Part I--The antibacterial effect. Arch Pharm (Weinheim) (1989) 0.77
[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancer. J Cancer Res Clin Oncol (1993) 0.77
Mammary tumor inhibiting [1,2-bis(2,6-dihalo-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes, III: Relationship between structure and estrogenic activity of the diamine ligands, their sulfatoplatinum(II) and diiodoplatinum(II) complexes. Arch Pharm (Weinheim) (1993) 0.76
[1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloro-platinum(II): an endocrine-active platinum complex with a specific prostatic tumor-inhibiting activity. Prostate (1989) 0.76
Nature of RNA synthesized at low and high ionic strength by DNA-dependent RNA-polymerase from Escherichia coli. Eur J Biochem (1969) 0.76
Expression of lipoprotein lipase gene in combined lipase deficiency. Biochim Biophys Acta (1989) 0.76
Computer modelling of estrogenic transcriptional activation can account for different types of dose-response curves of estrogens. J Steroid Biochem Mol Biol (1993) 0.76
Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation. Cancer Chemother Pharmacol (1992) 0.76
Stability and cellular studies of [rac-1,2-bis(4-fluorophenyl)-ethylenediamine][cyclobutane-1,1- dicarboxylato]platinum(II), a novel, highly active carboplatin derivative. J Cancer Res Clin Oncol (1998) 0.76
N,N'-Dialkyl-1,2-bis(hydroxyphenyl)ethylenediamines and N,N-dialkyl-4,5-bis(4-hydroxyphenyl)imidazolidines: syntheses and evaluation of their mammary tumor inhibiting activity. J Med Chem (1982) 0.76
[Development of new antiestrogens of the 3,3'-dihydroxy-alpha, beta-diethylstilbene-type and their evaluation on the DMBA-induced hormone dependent mammary carcinoma of the SD-rat (author's transl)]. J Cancer Res Clin Oncol (1980) 0.76
Expression of beta-1,4-galactosyltransferase gene during 3T3 cell growth. Biochim Biophys Acta (1991) 0.75
Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma. J Med Chem (1984) 0.75
Development of a parenterally administrable hydrosol preparation of the "third generation platinum complex" [(+/-)-1,2-bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II). Part 1. Preparation and studies on the stability and antitumor activity. Arch Pharm (Weinheim) (1995) 0.75
Influence of ring substituents on the antitumor effect of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes. J Cancer Res Clin Oncol (1988) 0.75
N,N'-Dialkylbis(dichlorophenyl)ethylenediamines and -imidazolidines: relationship between structure and estradiol receptor affinity. J Med Chem (1980) 0.75
[On the acyl migration of stereoisomers of N-(N-dimethyl-phenylalanyl)-ephedrine. 7. To the separation of organic bases by Craig-distribution]. Arch Pharm Ber Dtsch Pharm Ges (1967) 0.75
[Intraocular lenses - aphorisms of an operating practitioner (author's transl)]. Klin Monbl Augenheilkd (1979) 0.75
[Conversions of aliphatic substituted alpha-aminonitriles with metallic sodium in toluol. VI. Conversion of alpha-aminonitriles]. Arch Pharm Ber Dtsch Pharm Ges (1969) 0.75
[The action mechanisms of local anesthetics. 9. N-aminoacyl-beta-phenylalkylamine tested for development of antidepressive agents from psychotonics]. Pharmazie (1976) 0.75
[Dimerization of alpha-piperidinoacetonitrile with t-butylmagnesium chloride. IV. Conversion of alpha-aminonitriles]. Arch Pharm Ber Dtsch Pharm Ges (1969) 0.75
[Dimer exchange products of aromatic substituted alpha-aminonitriles. VII. Conversion of alpha-aminonitriles]. Arch Pharm Ber Dtsch Pharm Ges (1969) 0.75
[Influence of solvents on the course of the reduction of Schiff bases with activated aluminum]. Arch Pharm Ber Dtsch Pharm Ges (1965) 0.75
[Effect of aminomethylating carcinostatics on experimental animal tumors. IV. On cytostatics]. Arzneimittelforschung (1966) 0.75
[On the effect of N-aminoacylephedrines, a new class of local anesthetics. Attempts at the preparation of presser active local anesthetics]. Arzneimittelforschung (1967) 0.75
[Synthesis of local anesthetically active alkoxybenhydrylalkylamine from Schiff's bases and phenyllithium]. Arch Pharm Ber Dtsch Pharm Ges (1966) 0.75
[Synthesis of hexestrol-isostereo meso-N,N'-dimethyl-alfa,alfa'-di(4-hydroxyphenyl)-ethylenediamine]. Arch Pharm Ber Dtsch Pharm Ges (1970) 0.75
[14C-labeling of D 16,427, a new positive inotropic agent]. Arch Pharm (Weinheim) (1986) 0.75
Anticancer drugs: estrophilic cisplatin derivatives. Cancer Treat Rev (1987) 0.75
[Antineoplastic effect of N,N',N''-trihydroxymethylmelamine and analogous compounds. 23. Cytostatic agents]. Arch Pharm (Weinheim) (1973) 0.75
[Synthesis of spasmolytic N-diphenylacetamidomethyl-dimethylalkyl-ammonium iodides]. Arch Pharm (Weinheim) (1972) 0.75
[Studies on the mechanism of the reduction of Schiff bases with activated aluminum in ethyl alcohol. 6. On cytostatic agents]. Arch Pharm Ber Dtsch Pharm Ges (1967) 0.75
[Synthesis and pharmacological test of N-(3'-methoxy-benzamidomethyl)-D-norephedrine and Analogous Compounds (author's transl)]. Arch Pharm (Weinheim) (1976) 0.75
[Reaction method of alpha-aminoacetonitrile with metallic sodium in liquid ammonia. 8. Conversion of alpha-aminonitriles]. Arch Pharm Ber Dtsch Pharm Ges (1969) 0.75
[Antimycobacterial effect of N-alkylbenzylamines]. Pharmazie (1977) 0.75
[Configurative assignment of the diastereomer N,N'-dialkyl- , '-diphenylethylenediamines by nucleic resonance spectroscopy. 19. Cytostatics]. Arzneimittelforschung (1972) 0.75
[The working mechanism of local anesthetics. 8. Preparation of enantiomer N-phthalylamino carbonic acids]. Pharmazie (1976) 0.75
[Mammary-tumor-inhibiting antiestrogens of the 3,3'-dihydroxy-alpha, beta-dialkylstilbene type (author's transl)]. Arch Pharm (Weinheim) (1980) 0.75
[Azomethines and oxazolidines from norfenefrine. Development of compounds with prolonged action and blood pressure increasing effect]. Arch Pharm (Weinheim) (1975) 0.75
[Relations between physical-chemical properties and antimicrobial effect of beta-amino-ketones. 9. Cytostatics]. Arzneimittelforschung (1970) 0.75
[Mechanistic studies on the formation of diphenylethylene-diamines from benzylidenealkylamines and activated aluminum. 5. On cytostatic agents]. Arch Pharm Ber Dtsch Pharm Ges (1967) 0.75
[Studies on the mechanism of action of local anesthetics. 6. Binding of local anesthetics of complementary membranes structures]. Pharmazie (1972) 0.75
Effect of estrophilic platinum complex on the mouse uterus. Virchows Arch B Cell Pathol Incl Mol Pathol (1987) 0.75
[Studies of mechanism of action on antimicrobically effective beta-aminoketones]. Pharm Acta Helv (1969) 0.75
Design of metallocenic drugs. IARC Sci Publ (1986) 0.75
[The mode of action of local anesthetics. 7. Synthesis of enantiomeric N-aminoacyl-2.6.-dimethylaniline, -benzylamine and-2-phenylethylamine]. Pharmazie (1976) 0.75
A simple method of delayed processing of tumor tissue in a soft agar clonogenic assay. J Cancer Res Clin Oncol (1988) 0.75
[Synthesis and tumor inhibiting effect of N-(bis(2-chlorethyl)-aminomethyl)-amides. 21. Cytostatic agents]. Arch Pharm (Weinheim) (1973) 0.75
[Synthesis and local anesthetic effect of N-piperidino-methyl-4-alkoxybenzamides]. Arch Pharm Ber Dtsch Pharm Ges (1970) 0.75
[Experimental chemotherapy of mammary neoplasms. A review]. Pharmazie (1976) 0.75
[The relationship between structure and tuberculostatic effect in the benzylamine group]. Pharmazie (1976) 0.75